The following publications are possibly variants of this publication:
- Multi-omic Pathway and Network Analysis to Identify Biomarkers for Hepatocellular CarcinomaMegan E. Barefoot, Rency S. Varghese, Yuan Zhou, Cristina Di Poto, Alessia Ferrarini, Habtom W. Ressom. embc 2019: 1350-1354 [doi]
- Comprehensive analysis of KLF2 as a prognostic biomarker associated with fibrosis and immune infiltration in advanced hepatocellular carcinomaXue-Qin Chen, Jie Ma, Di Xu, Zuo-Lin Xiang. bmcbi, 24(1):270, December 2023. [doi]
- Correction: Comprehensive analysis of KLF2 as a prognostic biomarker associated with fibrosis and immune infiltration in advanced hepatocellular carcinomaXue-Qin Chen, Jie Ma, Di Xu, Zuo-Lin Xiang. bmcbi, 25(1):7, December 2024. [doi]
- Integrated Analysis of an lncRNA-Associated ceRNA Network Reveals Potential Biomarkers for Hepatocellular CarcinomaJie Yang, Qingchun Xu, Zhenyu Wang, Xun Lu, Liukui Pan, Jun Wu, Chen Wang. jcb, 28(3):330-344, 2021. [doi]
- Integrative analysis of genetic and epigenetic profiling of lung squamous cell carcinoma (LSCC) patients to identify smoking level relevant biomarkersBidong Ma, Zhiyou Huang, Qian Wang, Jizhou Zhang, Bin Zhou, Jiaohong Wu. biodatamining, 12(1), 2019. [doi]
- Identification of chromosomal instability-associated genes as hepatocellular carcinoma progression-related biomarkers to guide clinical diagnosis, prognosis and therapyYueyang Hu, Chuanyu Tang, Wen Zhu, Hanjie Ye, Yuxing Lin, Ruixuan Wang, Tianjun Zhou, Sai Wen, Jian Yang, Chihua Fang. cbm, 148:105896, 2022. [doi]